Trump Administration Strikes Historic Drug Price Deal: What is next for Eli Lilly and Novo Nordisk
The White House announced Thursday that blockbuster GLP-1 weight-loss and diabetes drugs—such as Ozempic, Wegovy, and Zepbound, will soon...
The White House announced Thursday that blockbuster GLP-1 weight-loss and diabetes drugs—such as Ozempic, Wegovy, and Zepbound, will soon...
Nvidia Corp. ($NVDA) has officially made history, becoming the first publicly traded company to reach a $5 trillion market...
Eli Lilly is sharply increasing the list price of its blockbuster weight-loss drug Mounjaro in the UK, marking a...
Eli Lilly reports its highly anticipated first-quarter earnings on May 1, 2025, before the market opens. As one of...
On Wednesday, President Donald Trump will convene an “Invest in America” event at the White House, bringing together CEOs...
A needle-free alternative is on the way. Eli Lilly’s daily obesity pill, orforglipron, met key goals in a major...
Morgan Stanley analysts are setting a bullish tone for the upcoming earnings season, with specific companies expected to outperform....
U.S. stock futures were mixed Monday, with strength in the Dow and S&P 500, while weakness in AI bellwether Nvidia...
